Publications by authors named "U Diva"

Claim this Profile
P
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
Laura H Mariani, Howard Trachtman, Aliza Thompson, Barbara S Gillespie, Michelle Denburg, Ulysses Diva

Am J Kidney Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Michelle N Rheault, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Ulysses Diva

N Engl J Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler, Ulysses A Diva

Lancet· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial.
Howard Trachtman, Ulysses Diva, Edward Murphy, Kaijun Wang, Jula Inrig

Kidney Int Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis.
Sharon F Freedman, Monte A Del Monte, Ulysses Diva, Sean P Donahue, Arlene V Drack

J AAPOS· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis